longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Harrow Q2 FY26 net loss widens to $17.27 million; revenue rises 11% to $70.66 million

PUBT
Aug 10, 2026 at 08:07 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Harrow Inc. reported Q2 FY26 revenue of $70.66 million, an 11% year-over-year increase, while the GAAP net loss widened to $17.27 million. Non-GAAP adjusted EBITDA swung to a $1.23 million loss. The company reiterated its 2026 revenue guidance of $350-$365 million and expects the TYRVAYA acquisition to close in the second half of 2026.

  • Harrow posted Q2 revenue of $70.7 million, up 60% sequentially and 11% year over year. * GAAP net loss widened to $17.27 million; GAAP diluted loss per share was $0.46. * Non-GAAP adjusted EBITDA swung to a loss of $1.23 million from a profit a year earlier. * VEVYE revenue rose to $29.4 million, up about 40% sequentially and about 58% year over year; IHEEZO revenue was $15.6 million. * Reiterated 2026 guidance for revenue of $350 million-$365 million; expects TYRVAYA acquisition to close in the second half of 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harrow Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608101605PRIMZONEFULLFEED9807168) on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Login to unlock638characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Sep 9, 2026 at 11:04 AMWith AMZN on board, is QCOM's AI second S-curve locked in?

Related Stocks

Harrow

Harrow

USHROW

-0.79%

Harrow Health Pref Share HROWM 11.875 12/31/27

Harrow Health Pref Share HROWM 11.875 12/31/27

USHROWM

0.00%

Harrow Health Pref Share HROWL 8.625 04/30/26

Harrow Health Pref Share HROWL 8.625 04/30/26

USHROWL

0.00%

LongbridgeAI